全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

NLR、RDW、CRP、NT-proBNP的动态监测对于COPD-PH的应用价值研究
Research on the Application Value of Dynamic Monitoring of NLR, RDW, CRP, NT-proBNP for COPD-PH

DOI: 10.12677/ACM.2021.1112902, PP. 6086-6092

Keywords: 慢性阻塞性肺疾病,肺动脉高压,动态监测
Chronic Obstructive Pulmonary Disease
, Pulmonary Hypertension, Dynamic Monitoring

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:通过动态监测慢性阻塞性肺疾病(慢阻肺,COPD)合并肺动脉高压(PH)患者的中性粒细胞/淋巴细胞的比值(NLR)、红细胞体积分布宽度(RDW)、C反应蛋白(CRP)及氨基末端脑钠肽前体(NT-proBNP)的变化,探讨其在慢阻肺合并肺动脉高压(COPD-PH)中的应用价值。方法:回顾性分析自2018年1月1日至2020年6月30日在青岛大学附属医院住院的COPD患者的临床资料,通过入院后24小时内行心脏超声检查估测肺动脉收缩压(PASP),选取105例COPD-PH患者(心超检查结果示PASP ≥ 35 mmHg),根据PASP结果将患者分为轻度PH组(A组,30例,35 mmHg ≤ PASP < 50 mmHg),中度PH组(B组,37例,50 mmHg ≤ PASP < 70 mmHg),重度PH组(C组,38例,PASP ≥ 70 mmHg),分别于入院第1 d、入院第3 d、入院第6 d、出院前1 d抽取清晨空腹静脉血,检测NLR、RDW、CRP、NT-proBNP在治疗前后的差异,观察其对COPD-PH的影响。结果:B、C两组NLR、RDW、CRP、NT-proBNP入院第1 d数值均高于A组,各组入院第3 d、第6 d、出院前1 d数值与入院第1 d对比绝大部分各项指标明显降低,差异有统计学意义(P < 0.05),但C组NLR数值入院第3 d与入院第1 d对比差异无统计学意义,而入院第6 d、出院前1 d数值与入院第1 d对比差异有统计学意义(P < 0.05)。结论:NLR、RDW、CRP、NT-proBNP具有检测快捷、简便的特点,并随着COPD-PH患者的PASP升高呈上升趋势,治疗过程中均显著下降,可作为治疗效果及预后评价指标。
Objective: To dynamically monitor the neutrophil/lymphocyte ratio (NLR), red blood cell volume distribution width (RDW), and C-reactive protein (CRP), and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients suffer from chronic obstructive pulmonary disease (COPD) with pulmonary hypertension (PH), and to explore its application value in COPD with pulmonary hypertension (COPD-PH). Methods: A retrospective analysis of the clinical data of COPD patients hospitalized in Qingdao University Affiliated Hospital from January 1, 2018 to June 30, 2020, was performed to estimate the pulmonary artery systolic pressure (PASP) through cardiac ultrasound within 24 hours after admission. 105 COPD-PH patients were selected (PASP ≥ 35 mmHg). According to PASP results, the patients were divided into mild PH group (group A, 30 cases, 35 mmHg ≤ PASP < 50 mmHg), moderate PH group (group B, 37 cases, 50 mmHg ≤ PASP < 70 mmHg), severe PH group (group C, 38 cases, PASP ≥ 70 mmHg). Early morning fasting venous blood was drawn on the first day of admission, the third day of admission, the sixth day of admission, and the 1 day before discharge to detect the difference of NLR, RDW, CRP, and NT-proBNP before and after treatment, and observe its effect on COPD-PH. Results: The values of NLR, RDW, CRP, and NT-proBNP on the first day of admission in groups B and C were higher than those in group A. The values on the 3 day of admission, 6 day of admission, and 1 day before discharge of each group were significantly lower than those on the first day of admission, the difference was statistically significant (P < 0.05), but there was no significant difference between the NLR values of group C on the 3rd day of admission and the 1st day of admission, and the values on the 6th day of admission and 1d before discharge were

References

[1]  Singh, D., Agusti, A., Anzueto, A., et al. (2019) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The GOLD Science Committee Report 2019. European Respiratory Journal, 53, Article ID: 1900164.
https://doi.org/10.1183/13993003.00164-2019
[2]  Wang, C., Xu, J., Yang, L., et al. (2018) Prevalence and Risk Factors Of Chronic Obstructive Pulmonary Disease in China (the China Pulmonary Health [CPH] Study): A National Cross-Sectional Study. The Lancet, 391, 1706-1717.
https://doi.org/10.1016/S0140-6736(18)30841-9
[3]  Mathers, C.D. and Loncar, D. (2006) Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLOS Medicine, 3, e442.
https://doi.org/10.1371/journal.pmed.0030442
[4]  Hayes, D., Daniels, C.J., Mansour, H.M., et al. (2013) Right Heart Catheterization Measuring Central Hemodynamics in Cystic Fibrosis during Exercise. Respiratory Medicine, 107, 1365-1369.
https://doi.org/10.1016/j.rmed.2013.02.020
[5]  Poor, H.D., Girgis, R. and Studer, S.M. (2012) World Health Organization Group III Pulmonary Hypertension. Progress in Cardiovascular Diseases, 55, 119-127.
https://doi.org/10.1016/j.pcad.2012.08.003
[6]  Sommer, N., Dietrich, A., Schermuly, R.T., et al. (2008) Regulation of Hypoxic Pulmonary Vasoconstriction: Basic Mechanisms. European Respiratory Journal, 32, 1639-1651.
https://doi.org/10.1183/09031936.00013908
[7]  Blanco, I., Tura-Ceide, O., Peinado, V.I., et al. (2020) Updated Perspectives on Pulmonary Hypertension in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 15, 1315-1324.
https://doi.org/10.2147/COPD.S211841
[8]  Humbert, M., Guignabert, C., Bonnet, S., et al. (2019) Pathology and Pathobiology of Pulmonary Hypertension: State of the Art and Research Perspectives. European Respiratory Journal, 53, Article ID: 1801887.
https://doi.org/10.1183/13993003.01887-2018
[9]  Zuo, H., Xie, X., Peng, J., et al. (2019) Predictive Value of Novel Inflammation-Based Biomarkers for Pulmonary Hypertension in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Analytical Cellular Pathology (Amsterdam), 2019, Article ID: 5189165.
https://doi.org/10.1155/2019/5189165
[10]  Nakayama, S., Chubachi, S., Sakurai, K., et al. (2020) Characteristics of Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension Assessed by Echocardiography in a Three-Year Observational Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease, 15, 487-499.
https://doi.org/10.2147/COPD.S230952
[11]  Gredic, M., Blanco, I., Kovacs, G., et al. (2021) Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease. British Journal of Pharmacology, 178, 132-151.
https://doi.org/10.1111/bph.14979
[12]  Sincer, I., Zorlu, A., Yilmaz, M.B., et al. (2012) Relationship between Red Cell Distribution Width and Right Ventricular Dysfunction in Patients with Chronic Obstructive Pulmonary Disease. Heart Lung, 41, 238-243.
https://doi.org/10.1016/j.hrtlng.2011.07.011
[13]  隋晓伟, 孙丽蓉. 红细胞分布宽度与慢性阻塞性肺疾病合并肺动脉高压的相关性[J]. 包头医学院学报, 2017, 33(12): 22-23.
https://doi.org/10.16833/j.cnki.jbmc.2017.12.009
[14]  Casserly, B. and Klinger, J.R. (2009) Brain Natriuretic Peptide in Pulmonary Arterial Hypertension: Biomarker and Potential Therapeutic Agent. Drug Design, Development and Therapy, 3, 269-287.
https://doi.org/10.2147/DDDT.S4805
[15]  Chang, W.T., Shih, J.Y., Hong, C.S., et al. (2021) Right Ventricular Expression of NT-proBNP Adds Predictive Value to REVEAL Score in Patients with Pulmonary Arterial Hypertension. ESC Heart Failure, 8, 3082-3092.
https://doi.org/10.1002/ehf2.13410

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133